Trademark: 90321319
Word
EVICORE SMARTCHOICE LAB
Status
Pending
Status Code
688
Status Date
Tuesday, December 12, 2023
Serial Number
90321319
Mark Type
4000
Filing Date
Monday, November 16, 2020
Published for Opposition
Tuesday, October 17, 2023

Trademark Owner History
EVICORE HEALTHCARE MSI, LLC - Owner At Publication
CareCore National, LLC - Original Applicant

Classifications
38 Electronic data interchange services in the field of healthcare transactions such as claims, eligibility, claim status, electronic remittance advice, prior authorizations, attachments and referrals that allow direct transaction, authorization and payment communications between healthcare providers, patients and payers; providing access to databases in the fields of medical diagnosis guidance and evidence-based healthcare
36 Medical benefit management services; medical benefit management services, namely, tracking, monitoring, assessing and analyzing information and statistics regarding patient prescription drug use, medical care, and healthcare habits, to identify potential cost savings and clinical benefits; claims administration services in the field of health insurance; medical insurance case and utilization review and insurance claims adjustment services for healthcare purchasers, payers, providers, and beneficiaries of health plans; administration of managed health care plans
35 Medical cost management; managed care services, namely, utilization review and pre-certification and post-certification services in the fields of inpatient admission management, molecular genomic lab services, comprehensive lab services, and diagnostic lab services, specialty drug medical benefit; cost management for the health care benefit plans of others; managed care services, namely, electronic processing of health care information; organization and coordination of health care services, namely, appointment coordination services and arranging managed care contractual services in the fields of diagnostic imaging, advanced imaging, nuclear medicine, radiation therapy, medical oncology medical benefit, medical oncology pharmacy benefit, cardiac and nuclear cardiac imaging, echo stress testing, diagnostic heart catheterization, ultrasound services, sleep management testing and treatment, sleep diagnostics, pap therapy devices and supplies, therapy support services, cardiac device care, post-acute care management, durable medical equipment, home infusion, bundled payments, musculoskeletal care, spine surgery, joint surgery, interventional pain, implant management, inpatient admission management, molecular genomic lab services, comprehensive lab services, and diagnostic lab services, gastroenterology, upper endoscopy, colonoscopy, lower endoscopy, capsule endoscopy, specialty drug medical benefit, occupational therapy, physical therapy, speech therapy, chiropractic care, acupuncture, massage therapy, and opioid management; evidenced-based health care cost management services and healthcare utilization and review services; managed care services, namely, electronic processing of health care information via the internet; health care cost management services for healthcare benefit plans of others and risk-bearing provider organizations being medical cost management services
42 Software as a service (SAAS) services featuring software for use in connection with evidence-based healthcare and insurance, namely, the development and implementation of algorithms and analytical models from evidence-based medical criteria for purposes of a medical utilization review and reporting, and verifying the requesting provider's adherence to evidence-based medicine guidelines and determining the appropriate intensity of medical utilization review based upon the requesting provider's prior history; application service provider (ASP), featuring software for use in developing, analyzing, and maintaining information and database management in the fields of healthcare, benefits programs, employee productivity, and risk management; quality management services, namely, quality evaluation and analysis, quality assurance, and quality control in the field of healthcare benefit plans for others; molecular and genetic lab services; software as a service (SAAS) services featuring software for optimizing healthcare utilization, managing utilization and financial risk for healthcare payers, assisting physicians in making clinical decision, and analyzing data to help health care providers track clinical decisions and develop best practices; software as a service (saas) services featuring software for use in automating tasks and storing data in the field of healthcare; providing online internet based non-downloadable computer software to perform prior authorizations services for healthcare providers and payers; providing online non-downloadable software for use by healthcare providers to search and retrieve clinical and non-clinical data from electronic medical records; computer services, namely, providing a cloud-enabled service in the nature of providing temporary use of non-downloadable cloud-based software for others that automates the prior authorization process for medical benefits
"LAB"

Trademark Events
Dec 12, 2023
Noa E-Mailed - Sou Required From Applicant
Oct 17, 2023
Official Gazette Publication Confirmation E-Mailed
Oct 17, 2023
Published For Opposition
Sep 27, 2023
Notification Of Notice Of Publication E-Mailed
Sep 12, 2023
Approved For Pub - Principal Register
Aug 22, 2023
Suspension Checked ¿ To Attorney For Action
May 16, 2023
Assigned To Examiner
Apr 19, 2023
Automatic Update Of Assignment Of Ownership
Feb 2, 2023
Report Completed Suspension Check Case Still Suspended
Jun 6, 2022
Report Completed Suspension Check Case Still Suspended
Nov 4, 2021
Notification Of Letter Of Suspension E-Mailed
Nov 4, 2021
Letter Of Suspension E-Mailed
Nov 4, 2021
Suspension Letter Written
Sep 28, 2021
Teas/Email Correspondence Entered
Sep 28, 2021
Correspondence Received In Law Office
Sep 28, 2021
Teas Response To Office Action Received
Sep 27, 2021
Teas Change Of Correspondence Received
Sep 27, 2021
Attorney/Dom.Rep.Revoked And/Or Appointed
Sep 27, 2021
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Mar 29, 2021
Notification Of Non-Final Action E-Mailed
Mar 29, 2021
Non-Final Action E-Mailed
Mar 29, 2021
Non-Final Action Written
Mar 24, 2021
Assigned To Examiner
Jan 14, 2021
New Application Office Supplied Data Entered
Nov 19, 2020
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24